The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Halcion: An Independent Assessment of Safety and Efficacy Data
Bliwise, D. L., W. F. Seidel, S. A. Cohen, N. G. Bliwise, and W. C. Dement. 1988. Profile of mood state changes during and after 5 weeks of nightly triazolam administration. Journal of Clinical Psychiatry 49(9):349-355.
Bonnet, M. H., and D. L: Arand. 1990. The use of triazolam in older patients with periodic leg movements, fragmented sleep and daytime sleepiness. Journal of Gerontology 45(4):139-144.
Bonnet, M. H., and D. L. Arand. 1991. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging (Milano) 3:313-324.
Chaudoir, P. J., N. L. Bodkin, J. O'Donnell, A. Anderson, and R. L. Holland. 1990. A comparative study of zopiclone and triazolam in patients with insomnia. International Clinical Psychopharmacology 5(Suppl. 2):21-27.
Derry, C. L., P. D. Kroboth, A. L. Pittenger, F. J. Kroboth, S. E. Corey, and R. B. Smith. 1995. Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men. Journal of Clinical Psychopharmacology 15:197-205.
Ducic, I., G. Puia, S. Vicini, and E. Costa. 1993. Triazolam is more efficacious than diazepam in a broad spectrum of recombinant GABAA receptors. European Journal of Pharmacology 244:29-35.
Eberts, F. S., Jr., Y. Philopoulos, L. M. Reineke, and R. W. Vliek. 1981. Triazolam disposition. Clinical Pharmacology and Therapeutics 29:81-93.
Elie, R., M. Frenay, P. Le Morvan, and J. Bourgouin. 1990. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. International Clinical Psychopharmacology 2(Suppl.):39-46.
Faure-Halley, C., D. Graham, S. Arbilla, and S. Z. Langer. 1993. Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor. European Journal of Pharmacology 246:283-287.
Fernandez-Guardiola, A., and J. L. Jurado. 1981. The effect of triazolam on insomniac patients using a laboratory sleep evaluation. Current Therapeutics Research 29:950-958.
Fleming, J. A., D. J. McClure, C. Mayes, R. Phillips, and J. Bourgouin. 1990. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. International Clinical Psychopharmacology 2(Suppl.):29-37.
Gales, B. J., and S. M. Menard. 1995. Relationship between the administration of selected medications and falls in hospitalized elderly patients. Annals of Pharmacotherapy 29(4):354-358.
Gibbons, R. D., D. R. Hedeker, I. Elkin, C. Waternaux, H. C. Kraemer, J. B. Greenhouse, M. T. Shea, S. D. Imber, S. M. Sotsky, and J. T. Watkins. 1993. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Archives of General Psychiatry 50:739-750.
Gibbons, R. D., D. R. Hedeker, S.C. Charles, and P. Frisch. 1994. A random-effects probit model for predicting medical malpractice claims. Journal of the American Statistical Association 89:760-767.
Gillin, J. C., C. L. Spinweber, and L. C. Johnson. 1989. Rebound insomnia: a critical review. Journal of Clinical Psychopharmacology 9:161-172.